Supply and Demand for Radiation Oncology in the United States: Updated Projections for 2015 to 2025

International Journal of Radiation Oncology Biology Physics

Volumn 96, Issue 3, 2016, Pages 493-500

  Pan, Hubert Y ^a   Haffty, Bruce G ^b   Falit, Benjamin P ^c   Buchholz, Thomas A ^a   Wilson, Lynn D ^d   Hahn, Stephen M ^a   Smith, Benjamin D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c Radiation Oncology Associates PA   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; DISEASES; ECONOMICS; EQUIVALENCE CLASSES; ONCOLOGY; PATIENT TREATMENT; POPULATION STATISTICS; RADIATION;

CENTERS FOR DISEASE CONTROLS; FULL TIME EQUIVALENTS; INITIAL TREATMENT; METHODS AND MATERIALS; RADIATION ONCOLOGISTS; RADIATION ONCOLOGY; SUPPLY AND DEMAND; UTILIZATION RATES;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; BREAST CARCINOMA; CANCER CONTROL; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; COLORECTAL CANCER; ESOPHAGUS CANCER; FEMALE; HODGKIN DISEASE; HUMAN; INTRADUCTAL CARCINOMA; KIDNEY CANCER; LARYNX CANCER; LEUKEMIA; LIFE TABLE; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MELANOMA; MIDDLE AGED; MOUTH CANCER; MYELOMA; NEOPLASM; NONHODGKIN LYMPHOMA; ONCOLOGY; OVARY CANCER; PANCREAS CANCER; POPULATION PROJECTION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION ONCOLOGIST; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; UNITED STATES; UTERINE CERVIX CANCER; UTERUS CANCER; COMPUTER SIMULATION; FORECASTING; HEALTH SERVICE; INCIDENCE; MANPOWER; NEEDS ASSESSMENT; NEOPLASMS; RADIATION ONCOLOGY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TRENDS; UTILIZATION; UTILIZATION REVIEW;

COMPUTER SIMULATION; FORECASTING; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INCIDENCE; MODELS, STATISTICAL; NEEDS ASSESSMENT; NEOPLASMS; RADIATION ONCOLOGY; RADIOTHERAPY; UNITED STATES; UTILIZATION REVIEW;

EID: 84969528752     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2016.02.064     Document Type: Article

References (26)

1. 1 Marin, J., Hamilton, B., Osterman, M., et al. Births: Final data for 2013. 2015, National Center for Health Statistics, Hyattsville, MD.
2. 2 Smith, B.D., Smith, G.L., Hurria, A., et al. Future of cancer incidence in the united states: Burdens upon an aging, changing nation. J Clin Oncol 27 (2009), 2758–2765.
3. 3 Smith, B.D., Haffty, B.G., Wilson, L.D., et al. The future of radiation oncology in the United States from 2010 to 2020: Will supply keep pace with demand?. J Clin Oncol 28 (2010), 5160–5165.
4. 4 Hortobagyi, G.N., American Society of Clinical Oncology. A shortage of oncologists? The American Society of Clinical Oncology workforce study. J Clin Oncol 25 (2007), 1468–1469.
5. 5 Ahmed, A.A., Holliday, E.B., Deville, C., et al. Attracting future radiation oncologists: An analysis of the national resident matching program data trends from 2004 to 2015. Int J Radiat Oncol Biol Phys 93 (2015), 965–967.
6. 6 Shah, C., Expanding the number of trainees in radiation oncology: Has the pendulum swung too far?. Int J Radiat Oncol Biol Phys 85 (2013), 1157–1158.
7. 7 Colby, S., Ortman, J.M., Projections of the size and composition of the U.S. population: 2014 to 2060. 2015, U.S. Census Bureau, Washington, DC.
8. 8 Clegg, L.X., Feuer, E.J., Midthune, D.N., et al. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst 94 (2002), 1537–1545.
9. 9 Surveillance, Epidemiology, and End Results (SEER) program SEER*stat database: Incidence - SEER 18 regs research data with delay adjustment, malignant only, Nov 2014 sub (2000-2012), 2015, National Cancer Institute, Bethesda, MD.
10. 10 Surveillance, Epidemiology, and End Results (SEER) program SEER*stat database: Incidence - SEER 18 regs research data, Nov 2014 sub (2000-2012), 2015, National Cancer Institute, Bethesda, MD.
11. 11 SEER cancer statistics factsheets: All cancer sites. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/statfacts/html/all.html. Accessed December 9, 2015.
12. 12 Pohar, S., Fung, C.Y., Hopkins, S., et al. American Society for Radiation Oncology (ASTRO) 2012 workforce study: The radiation oncologists’ and residents’ perspectives. Int J Radiat Oncol Biol Phys 87 (2013), 1135–1140.
13. 13 Arias, E., United States life tables, 2011. 2015, National Center for Health Statistics, Hyattsville, MD.
14. 14 Mahmood, U., Hanlon, A.L., Koshy, M., et al. Increasing national mastectomy rates for the treatment of early stage breast cancer. Ann Surg Oncol 20 (2013), 1436–1443.
15. 15 Hughes, K.S., Schnaper, L.A., Bellon, J.R., et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: Long-term follow-up of CALGB 9343. J Clin Oncol 31 (2013), 2382–2387.
16. 16 Klotz, L., Zhang, L., Lam, A., et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 28 (2010), 126–131.
17. 17 Timmerman, R., Paulus, R., Galvin, J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303 (2010), 1070–1076.
18. 18 Chang, J.Y., Senan, S., Paul, M.A., et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: A pooled analysis of two randomised trials. Lancet Oncol 16 (2015), 630–637.
19. 19 Smith BD, Jiang J, Shih Y-CT, et al. Complication and economic burden of local therapy options for early breast cancer. Abstract presented at: 38th Annual CTRC-AACR San Antonio Breast Cancer Symposium, December 8-12, 2015; San Antonio, TX.
20. 20 Pan, H.Y., Shaitelman, S.F., Perkins, G.H., et al. Implementing a real-time electronic data capture system to improve clinical documentation in radiation oncology. J Am Coll Radiol 13 (2016), 401–407.
21. 21 Pan, H., Simpson, D.R., Mell, L.K., et al. A survey of stereotactic body radiotherapy use in the United States. Cancer 117 (2017), 4566–4572.
22. 22 Aneja, S., Smith, B.D., Gross, C.P., et al. Geographic analysis of the radiation oncology workforce. Int J Radiat Oncol Biol Phys 82 (2012), 1723–1729.
23. 23 Milano, M.T., Katz, A.W., Zhang, H., et al. Oligometastases treated with stereotactic body radiotherapy: Long-term follow-up of prospective study. Int J Radiat Oncol Biol Phys 83 (2012), 878–886.
24. 24 Timmerman, R.D., Herman, J., Cho, L.C., Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice. J Clin Oncol 32 (2014), 2847–2854.
25. 25 Delaney, G., Jacob, S., Featherstone, C., et al. The role of radiotherapy in cancer treatment: Estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 104 (2005), 1129–1137.
26. 26 Walker, G.V., Giordano, S.H., Williams, M., et al. Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries. Int J Radiat Oncol Biol Phys 86 (2013), 686–693.